对抗体与药物结合物的定量和药物动力学分析的生物分析方法的最新进展
R M Naseer Khan1, Yi Zeng1, Abdul-Azeez A Lanihun1
1Clinical Pharmacology Laboratory, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 5A03, Bethesda, Maryland, 20892, USA.
The AAPS journal
|September 4, 2025
概括
准确的抗体药物联合体 (ADC) 鉴定对于开发新的癌症疗法至关重要. 本综述强调了先进的生物分析方法和药物动力学建模,以提高ADC的安全性和有效性.
科学领域:
- 生物制药分析
- 药物动力学和药物代谢
- 癌症治疗药物
背景情况:
- 抗体与药物合物 (ADC) 是一个复杂的治疗类别,它结合了抗体特异性和细胞毒性有效载荷.
- ADC 的结构异质性和复杂性对准确的表征和定量提出了重大生物分析挑战.
- 强大的分析方法和药物动力学建模对于开发安全有效的抗药剂至关重要.
研究的目的:
- 审查ADC表征的生物分析方法的最新进展.
- 讨论ADC开发的基本药理动力学 (PK) 建模方法.
- 为增强ADC特征和促进治疗开发提供见解.
主要方法:
- 用于检测和定量ADC的联结试验 (LBA).
- 液体染色体-双重质谱 (LC-MS/MS) 用于详细的ADC分析.
- 混合LBA-LC-MS/MS平台集结绑定和质谱.
- 人口PK模型,生理学基础的药物动力学 (PBPK) 和定量系统药理学 (QSP) 模型用于机制理解.
主要成果:
- 最近的进展为ADC生物分析提供了更高的准确性和灵敏度.
- 先进的 PK 模型 (PBPK,QSP) 能够详细描述 ADC 配置,包括有效载荷解和 DAR 变性.
- 将生物分析数据与PK建模集成,可以增强体内ADC行为的理解.
结论:
- 强大的生物分析方法对于解决ADC复杂性至关重要.
- 先进的PK建模为ADC的药理动力学和动力学提供了重要的见解.
- 整合这些方法有助于开发更安全,更有效的ADC疗法.
相关概念视频
Protein-Drug Binding: Determination Methods
302
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
302
Drug Concentrations: Measurements
576
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
576
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Drug Distribution: Plasma Protein Binding
6.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.6K


